Ranibizumab Injections

Novartis Pharma Schweiz AG🇨🇳 National Medical Products Administration

Approval Id: 286f886113ceb31b
Approval Number: 国药准字SJ20181010
Generic Name: 雷珠单抗注射液
Generic Name En: Ranibizumab Injections
Trade Name: 诺适得
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 10mg/ml，每支装量0.165ml
Reg Date: 2022-11-17
Expired Date: 2027-11-16
Company Name: Novartis Pharma Schweiz AG
Production Company Name: Vetter Pharma-Fertigung GmbH & Co. KG
Company Detail Path: /organization/novartis-pharma-schweiz-ag
Production Company Detail Path: /organization/vetter-pharma-fertigung-gmbh-and-co-kg

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Nov 17, 2022

Approval ID

286f886113ceb31b

Type

生物制品